Kennedy Capital Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,033
| Closed | -$251K | – | 682 |
|
|
2023
Q1 | $251K | Buy |
8,033
+199
| +3% | +$6.23K | 0.01% | 593 |
|
|
2022
Q4 | $551K | Sell |
7,834
-9
| -0.1% | -$634 | 0.02% | 549 |
|
|
2022
Q3 | $675K | Buy |
7,843
+1
| +0% | +$86 | 0.02% | 526 |
|
|
2022
Q2 | $649K | Sell |
7,842
-29,092
| -79% | -$2.41M | 0.02% | 521 |
|
|
2022
Q1 | $6.14M | Sell |
36,934
-7,122
| -16% | -$1.18M | 0.15% | 260 |
|
|
2021
Q4 | $7.37M | Sell |
44,056
-1,059
| -2% | -$177K | 0.16% | 245 |
|
|
2021
Q3 | $3.9M | Sell |
45,115
-774
| -2% | -$66.9K | 0.09% | 387 |
|
|
2021
Q2 | $2.49M | Sell |
45,889
-5,066
| -10% | -$275K | 0.05% | 469 |
|
|
2021
Q1 | $3.04M | Sell |
50,955
-1,902
| -4% | -$113K | 0.06% | 466 |
|
|
2020
Q4 | $2.76M | Sell |
52,857
-244
| -0.5% | -$12.7K | 0.06% | 463 |
|
|
2020
Q3 | $2.57M | Buy |
53,101
+29,069
| +121% | +$1.41M | 0.07% | 448 |
|
|
2020
Q2 | $1.25M | Buy |
+24,032
| New | +$1.25M | 0.04% | 558 |
|